Insight Molecular Diagnostics Inc. (IMDX) SEC filings
IMDXNasdaqIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 7/30
$1.78−0.08 (-4.30%)
Close on Nov 17, 2026Market cap $58.25MP/E –Yield –
SEC filings
40 of Insight Molecular Diagnostics's most recent filings on SEC EDGAR
| Document | Form | Period | Filed | Source |
|---|---|---|---|---|
| Quarterly report | 10-Q | Sep 30, 2026 | Nov 16, 2026 | SEC EDGAR |
| Current report | 8-K | Nov 16, 2026 | Nov 16, 2026 | SEC EDGAR |
| Current report | 8-K | Sep 15, 2026 | Sep 21, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2026 | Aug 10, 2026 | SEC EDGAR |
| Current report | 8-K | Aug 10, 2026 | Aug 10, 2026 | SEC EDGAR |
| Current report | 8-K | Jun 11, 2026 | Jun 17, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2026 | May 13, 2026 | SEC EDGAR |
| Current report | 8-K | May 13, 2026 | May 13, 2026 | SEC EDGAR |
| Proxy statement | DEF 14A | Apr 30, 2026 | Apr 30, 2026 | SEC EDGAR |
| Current report | 8-K | Apr 30, 2026 | Apr 30, 2026 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2025 | Mar 26, 2026 | SEC EDGAR |
| Current report | 8-K | Mar 26, 2026 | Mar 26, 2026 | SEC EDGAR |
| Current report | 8-K | Feb 20, 2026 | Feb 26, 2026 | SEC EDGAR |
| Current report | 8-K | Feb 10, 2026 | Feb 12, 2026 | SEC EDGAR |
| Current report | 8-K | Feb 11, 2026 | Feb 11, 2026 | SEC EDGAR |
| Current report | 8-K | Nov 10, 2025 | Nov 10, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2025 | Nov 10, 2025 | SEC EDGAR |
| Current report | 8-K | Sep 28, 2025 | Oct 2, 2025 | SEC EDGAR |
| Current report | 8-K | Sep 16, 2025 | Sep 19, 2025 | SEC EDGAR |
| Current report | 8-K | Aug 11, 2025 | Aug 11, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2025 | Aug 11, 2025 | SEC EDGAR |
| Current report | 8-K | Jun 27, 2025 | Jul 2, 2025 | SEC EDGAR |
| Current report | 8-K | Jun 13, 2025 | Jun 17, 2025 | SEC EDGAR |
| Proxy statement | DEF 14A | May 14, 2025 | May 14, 2025 | SEC EDGAR |
| Current report | 8-K | May 12, 2025 | May 12, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2025 | May 12, 2025 | SEC EDGAR |
| Current report | 8-K | Apr 11, 2025 | Apr 17, 2025 | SEC EDGAR |
| Current report | 8-K | Mar 24, 2025 | Mar 24, 2025 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2024 | Mar 24, 2025 | SEC EDGAR |
| Current report | 8-K | Mar 4, 2025 | Mar 10, 2025 | SEC EDGAR |
| Current report | 8-K | Feb 6, 2025 | Feb 10, 2025 | SEC EDGAR |
| Current report | 8-K | Jan 2, 2025 | Jan 8, 2025 | SEC EDGAR |
| Current report | 8-K | Nov 12, 2024 | Nov 12, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2024 | Nov 12, 2024 | SEC EDGAR |
| Current report | 8-K | Oct 11, 2024 | Oct 15, 2024 | SEC EDGAR |
| Current report | 8-K | Oct 2, 2024 | Oct 3, 2024 | SEC EDGAR |
| Proxy statement | DEF 14A | Sep 25, 2024 | Sep 25, 2024 | SEC EDGAR |
| Current report | 8-K | Aug 9, 2024 | Aug 9, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2024 | Aug 8, 2024 | SEC EDGAR |
| Current report | 8-K | Aug 8, 2024 | Aug 8, 2024 | SEC EDGAR |
See a number that looks wrong?